Home › Upcoming votes › IMPACT BIOMEDICAL INC.
Read the proxy statement on EDGAR
Ballot read from the proxy statement and checked. As listed in IMPACT BIOMEDICAL INC.’s proxy statement, with the board’s recommendation on each item.
| # | Item | Proposed by | Board recommends | Last year (same kind of item) |
|---|---|---|---|---|
| 1 | BUSINESS COMBINATION PROPOSAL | Board | For | — |
| 2 | CORPORATE DOCUMENT PROPOSAL | Board | For | — |
| 3 | Director Election Proposal Director election |
Board | For | 8 nominees; support 99.8% to 99.9% |
| 4 | Auditor Ratification Proposal Auditor |
Board | For | — |
| 5 | "FOR" the Advisory Vote on Executive Compensation Proposal; and Say on pay |
Board | For | 99.8% support |
| 6 | ADJOURNMENT OF THE SPECIAL MEETING Adjournment |
Board | For | — |
From IMPACT BIOMEDICAL INC.’s Form 8-K, filed November 6, 2025, for the meeting held November 5, 2025 (read it on EDGAR). Support is the share of votes cast that were FOR: abstentions and broker non-votes are left out.
| Item | Support (of votes cast) | Reported outcome |
|---|---|---|
| Elect Director: Frank D. Heuszel | 99.9% | — |
| Elect Director: Elise Brownell | 99.8% | — |
| Elect Director: Melissa Sims | 99.8% | — |
| Elect Director: Castell Hibbert | 99.9% | — |
| Elect Director: David Keene | 99.8% | — |
| Elect Director: Christian Zimmerman | 99.9% | — |
| Elect Director: Jason Grady | 99.9% | — |
| Elect Director: Chan Heng Fai Ambrose | 99.8% | — |
| 2. Ratification of the appointment of Grassi & Co | 99.7% | — |
| 3. Approval on an advisory basis of the compensation of the named executive officers | 99.8% | — |
The meeting facts and ballot come from the SEC proxy filings listed above. Ballots are read from the proxy statement and checked against the filing’s own text; when that check does not pass, the page shows “see the proxy statement” instead of a ballot. Last year’s figures are the company’s official Form 8-K results and the managers’ Form N-PX reports. Nothing on this page predicts how any shareholder will vote, and it is not investment advice. How this works.